arBtrage CAPITALIZING MARKETS checking… Sign in

Arbutus Biopharma Corporation

ABUS Health Care Biotechnology: Pharmaceutical Preparations
$4.25
▼ -2.3% Today
as of Jun 7, 07:08 ET
Last 30 days +2.41% Apr 28 → Jun 05
$4.09 $4.24 $4.38 $4.53 $4.68 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.34
High
$4.36
Low
$4.21
Volume
$1M
Avg Vol
$1M
Mkt Cap
$909M
P/E (TTM)
Beta
52w High
$5.10
52w Low
$3.04
Div Yield
Shares Out
$197M

Overview

52-week range
$3.04
$5.10
59% of range
Avg surprise (last 1)
-44.4%
Avg reaction (last 2)
-0.5%
0% positive
Latest IV / EM
102%
EM ±14.1% · $4 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.13$0.12$0.37$0.62$0.87 Actual $-0.13Est $-0.09Actual $0.87 Mar/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-25M$29M$82M$135M$188M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $0.87 +769.2% 0.0% earnings
Wed May 14, 2025Mar/2025 $-0.13 $-0.09 -44.4% -0.9% earnings

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$179M$529,000$11M$2M$1M$2M
Cost of revenue
Gross profit
Operating income$169M$-9M$1M$-26M$-21M$-22M
Net income$170M$-8M$3M$-25M$-20M$-20M
EPS (diluted)

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$24M$18M$22M$37M$37M$36M$32M$63M
Inventory
Total current assets$277M$94M$97M$103M$117M$127M$133M$148M
Total assets$277M$95M$98M$103M$117M$132M$140M$160M
Long-term debt$0$0$0$0$0$0
Total liabilities$17M$18M$20M$20M$38M$34M$34M$38M
Total equity$260M$77M$77M$83M$79M$97M$107M$122M

Implied volatility — last 90 days

96%99%101%104%106% Jun 07 — IV 102% · EM ±14.1%

Sector peers